Early Switch-on of the Chemotactic Fractalkine Axis and Its Dynamic Variation in Pancreatic Cancer Invasion and Progression

Giuseppe Celesti; Paolo Bianchi; Fabio Grizzi; Federica Marchesi; Annarita Destro; Daoud Rahal; Paola Cappello; Massimo Roncalli; Alessandro Zerbi; Marco Montorsi; Francesco Novelli; Alberto Mantovani; Paola Allavena; Alberto Malesci; Luigi Laghi

doi:10.1016/s0016-5085(11)63427-6

Related publications

Article2008

M2036 Early Fractalkine Receptor (CX3CR1) Switch-On in Pancreatic Ductal Adenocarcinoma Is Associated with Local Neural Invasion

Luigi Laghi, Paolo Bianchi, Federica Marchesi, Paola Allavena, Marco Montorsi, Alberto Mantovani, Alberto Malesci

Article2013

Early expression of the fractalkine receptor CX3CR1 in pancreatic carcinogenesis

Giuseppe Celesti, G.Q. Di, Paolo Bianchi, Fabio Grizzi, Federica Marchesi, Gianluca Basso, Daoud Rahal, Gabriele Delconte, Myriam Catalano, Paola Cappello, Massimo Roncalli, Alessandro Zerbi, Marco Montorsi, Francesco Novelli, Alberto Mantovani, Paola Allavena, Alberto Malesci, Luigi Laghi

Article2018

Genetic dissection of the miR-200–Zeb1 axis reveals its importance in tumor differentiation and invasion

Alexandra C. Title, Sue‐Jean Hong, Nuno D. Pires, Lynn Hasenöhrl, Svenja Godbersen, Nadine Stokar‐Regenscheit, David Bartel, Markus Stoffel

Article2001

Genetic Evolution in the Metastatic Progression of Human Pancreatic Cancer Studied by CGH

Gemma Armengol, Gabriel Capellà, Lourdes Farré, aaa bbb, Rosa Miró, M.R. Caballı́n

Article2021

Role of non-coding RNAs in tumor progression and metastasis in pancreatic cancer

Lorenzo F. Sempere, Katherine Powell, Jatin Rana, Andrew A. Brock, Thomas D Schmittgen